Here are some of the latest health and medical news developments,
compiled by editors of
HealthDay:
Health Experts Warn of Loss of Momentum in
Fight Against Smoking
Noting that U.S. smoking rates are stagnant after nearly a decade of
decline, a coalition of public health organizations warned Wednesday that
the nation's progress in reducing smoking is at risk unless states
significantly increase funding for programs to prevent children from
smoking and help smokers quit.
The warning, contained in an annual report, assesses whether states are
keeping their promise to use proceeds from the 1998 state tobacco
settlement to fight tobacco use. This year, the report found that states
have increased funding for tobacco prevention and cessation programs by 20
percent — to $717.2 million, the highest level in six years.
But, most states still fail to fund these programs at minimum levels
recommended by the U.S. Centers for Disease Control and Prevention, and
the states combined are providing less than half of what the CDC has
recommended, the report said.
The report, “A Broken Promise to Our Children: The 1998 State Tobacco
Settlement Nine Years Later,” was released by the Campaign for
Erectile dysfunction impotence treatment Kids, the American Heart Association, the American Lung
Association and the American Cancer Society Cancer Action Network.
Among the report's findings:
- Only three states — Maine, Delaware and Colorado — currently fund
tobacco prevention programs at CDC minimum levels.
- Only 17 other states fund tobacco prevention programs at even half the
CDC's minimum amount.
- Thirty states and the District of Columbia are spending less than half
the CDC minimum, while Connecticut has appropriated no funding for tobacco
prevention this year.
- Total state funding for tobacco prevention amounts to less than 3
percent of the record $24.9 billion the states will collect this year from
the tobacco settlement and tobacco taxes. Just 6.4 percent of this
tobacco revenue would fund prevention programs in every state at CDC
minimum levels.
- The states' funding of tobacco prevention pales compared to the $13.4
billion a year spent on tobacco marketing and the nearly $100 billion
spent each year on health-care bills due to tobacco use.
The report comes as recent surveys have found that the nation's
progress in reducing smoking has stalled among both children and adults.
The CDC recently reported that 20.8 percent of adults smoked in 2006,
about the same as the 20.9 percent in 2004 and 2005. This followed a
steady decline between 1997 and 2004. High school smoking rates have
similarly stalled after declining from a high of 36.4 percent in 1997, and
23 percent of high school students still smoke, according to the most
recent CDC data cited by the report.
The CDC has attributed this stall to several factors, including cuts in
tobacco prevention funding, increases in tobacco marketing and stagnant
cigarette prices due to industry discounting.
“It is unacceptable to stand still in the fight against the number one
preventable cause of death in our country,” said William V. Corr,
executive director of the Campaign for Tobacco-Free Kids. “As the
Institute of Medicine and the President's Cancer Panel found, we know what
works to reduce smoking, save lives and save money by reducing
tobacco-related health care costs. What's needed is the political
leadership to fund and implement these measures as aggressively as the
tobacco companies continue to market their deadly and addictive products.”
Tobacco use is the nation's leading preventable cause of death, killing
more than 400,000 people and costing nearly $100 billion in health-care
bills each year, the report said.
—–
U.S. Cholesterol Average Drops to New Low
For the first time since it began in 1960, a national survey has found
that the average total cholesterol level among American adults is in the
ideal range. The average level in 2005-2006 was 199, according to the
survey of about 4,500 people 20 and older. A level of 200 or less is
desirable.
The National Center for Health Statistics conducts the blood test
survey in two-year intervals. The average total cholesterol level was 204
in 1999-2000 and 222 in 1960, the Associated Press reported.
The new survey also found that the percentage of adults with high
cholesterol (240 or higher) was 16 percent, compared to 20 percent in the
early 1990s. Among survey respondents, 65 percent of men and 75 percent of
women had been screened for high cholesterol in the previous five
years.
A primary reason for the positive news may be rising use of
cholesterol-lowering drugs in people 60 and older, said report author
Susan Schober, a senior erectile dysfunction blog
at the National Center for Health
Statistics, the AP reported.
“These age groups are the ones most likely to be treated with
medication,” she said.
—–
Annual U.S. Hospital Bill May Hit $1 Trillion
in 2008: Report
In 2005, U.S. hospitals charged a combined $873 billion for patient
treatment, nearly 90 percent more than the $462 billion cumulative
hospital bill in 1997, according to the latest News and Numbers
from the federal Agency for Healthcare Research and Quality.
Over the past several years, the average annual rate of increase in the
national hospital bill was 4.5 percent. At that rate, the annual tally may
hit $1 trillion by 2008, the report said.
Medicare paid the majority of the 2005 national hospital bill ($411
billion), followed by private insurers ($272 billion) and Medicaid ($124
billion). Uninsured patients accounted for $38 billion in charges. The
remaining $28 billion was paid for by other insurers, including Workers'
Compensation, TRICARE, Title V, and other government programs.
Five conditions accounted for a considerable chunk of the national
hospital bill: coronary artery disease ($46 billion); pregnancy and
childbirth ($44 billion); newborn infant care ($35 billion); heart attack
($32 billion); and congestive heart failure ($30 billion).
—–
U.S. and China Sign Drug and Food Safety
Accords
After nearly seven months of negotiations, the United States and China
have signed a pact to strengthen regulation of drugs and medical devices
exported to the United States, The New York Times reported.
Under the accord, all Chinese companies that make certain drugs for
export to the United States will have to register with Chinese regulators.
Drugs covered under the pact include the cholesterol-lowering drug
atorvastatin (Lipitor), the erectile dysfunction drug sildenafil (Viagra),
and the antibiotic gentamicin sulfate.
However, the pact does little to regulate bulk pharmaceutical
ingredients made by thousands of unlicensed chemical companies in China.
Some of those ingredients are substandard and dangerous, the newspaper
said.
While this agreement doesn't address all areas of concern, American
officials said it's an important first step in helping the Chinese
government regulate unlicensed companies, the Times reported.
The United States and China also signed an agreement that places new
registration and inspection requirements on 10 food products exported by
Chinese companies. The specified products include some preserved foods,
pet foods and farm-raised fish, all of which have come under suspicion of
being tainted, The Times said.
—–
People With Asian Ancestry Should Be Tested
Before Taking Carbamazepine: FDA
Drugs that contain the active ingredient over the counter erectile dysfunction medication will carry a
warning that patients with Asian ancestry should get a genetic blood test
before taking the drugs. The test will determine if they're at increased
risk for rare, but serious, skin reactions, the U.S. Food and Drug
Administration
said Wednesday.
Drugs that contain carbamazepine — sold under the brand names
Carbatrol, Equetro and Tegretol — are used to treat epilepsy, bipolar
disorder and neuropathic pain.
The risk of skin reactions — which can include lesions, blisters,
fever and itching — is about 1 to 6 people per 10,000 among new users of
such drugs in countries with mainly white populations. However, the risk
is estimated to be about 10 times higher in some Asian countries.
It's estimated that about 5 percent of patients being considered for
treatment with affected drugs are of Asian ancestry and would need to have
this test, which looks for an inherited variant of an immune system gene
found almost exclusively in people with Asian ancestry, the FDA said.
Patients who test positive shouldn't be treated with carbamazepine
unless the benefit clearly outweighs the increased risk of serious skin
reactions, the agency said.
—–
Excess Weight Reduces Women's Fertility:
Study
The more overweight a woman becomes, the less fertile she becomes,
according to results of a Dutch study published in the journal Human
Reproduction.
Researchers evaluated 3,000 women with fertility problems and found
that every point increase in body mass index (BMI) among women with a BMI
between 30 and 35 resulted in a 4 percent decrease in conception rates,
compared to women with a BMI between 21 and 29, BBC News
reported.
People with a BMI above 25 are considered overweight, while those with
a BMI over 30 are defined as obese.
The study also found that severely obese women (a BMI greater than 35)
were between 26 percent and 49 percent less likely to get pregnant than
those with a BMI between 21 and 29, BBC News reported.
“Given the increased prevalence of obesity, this is a worrying
finding,” said study leader Dr. Jan Willem van der Steeg. “We think women
should be informed about their lower pregnancy chances due to their
overweight.”
The researchers suggested that losing weight may increase the
likelihood of conception without the need for fertility treatment, BBC
News reported.
—–
Death Toll Reaches 30 in Uganda Ebola
Outbreak
The death toll from an Ebola outbreak in Uganda is now 30 out of 116
people known to have been infected with the deadly virus, Agence
France-Presse reported.
Health officials are still registering new infections in Bundibugyo
district, the epicenter of the outbreak and home to 250,000 people.
Hundreds of medical workers and villagers who have had physical contact
with infected patients are under observation, Ugandan authorities
said.
Experts from the U.S. Centers for Disease Control and Prevention are
continuing their testing for the virus, which has been identified as a new
strain of Ebola, AFP reported. The outbreak began in September but
was only identified as Ebola in late November.
Ebola is a blood-borne disease that's spread through contact with
bodily fluids.
